Infection with Clostridioides difficile (CDI), a common healthcare-associated infection, in-cludes symptoms ranging from mild diarrhea to severe cases of pseudomembranous colitis. Toxin A (TcdA) and toxin B (TcdB) cause cytotoxicity and cellular detachment from intestinal epithelium and are responsible for CDI symptomatology. Approximately 20% of C. difficile strains produce a binary toxin (CDT) encoded by the tcdA and tcdB genes, which is thought to enhance TcdA and TcdB toxicity; however, the role of CDT in CDI remains controversial. Here, we focused on describing the main features of CDT and its impact on the host, clinical relevance, epidemiology, and potential therapeutic approaches.
CITATION STYLE
Martínez-Meléndez, A., Cruz-López, F., Morfin-Otero, R., Maldonado-Garza, H. J., & Garza-González, E. (2022, May 1). An Update on Clostridioides difficile Binary Toxin. Toxins. MDPI. https://doi.org/10.3390/toxins14050305
Mendeley helps you to discover research relevant for your work.